![]() |
|
|
Vol. 284, Issue 3, 826-831, March 1998
Marine Biomedical Institute, University of Texas Medical Branch,
Galveston, Texas
We examined the non-opioid actions of various forms of dynorphin A
(DynA) on N-methyl-D-aspartate (NMDA) receptor channels in
isolated rat trigeminal neurons using the whole-cell patch recording
technique. All the dynorphins tested blocked NMDA-activated currents.
The blocking actions were voltage-independent. The IC50 was
0.26 µM for DynA(1-32), 6.6 µM for DynA(1-17) 7.4 µM for
DynA(1-13), 42.0 µM for DynA(1-10). DynA(1-8) had no detectable
blocking action on NMDA responses. Thus, the IC50s of
dynorphins for NMDA receptors increased 160-fold as the length of the
peptides decreased from 32 to 10 amino acids. Amidation of dynorphins
dramatically reduced their IC50s and eliminated the large
difference in the IC50s of various lengths of dynorphins.
The reduction in the IC50s of dynorphin amides could not be
explained by the resistance of the peptides to enzymatic degradation.
Our observations suggest that peptide processing affects dynorphin
blocking actions on NMDA responses. The positively charged residues,
lengths of the peptides and amidation may contribute to their
affinities for NMDA receptors.
This article has been cited by other articles:
![]() |
T. M. Laughlin, A. A. Larson, and G. L. Wilcox Mechanisms of Induction of Persistent Nociception by Dynorphin J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 6 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis The Glutamate Receptor Ion Channels Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62. [Abstract] [Full Text] [PDF] |
||||